Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 10;10(9):e037086.
doi: 10.1136/bmjopen-2020-037086.

Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme

Rachael L Murray  1   2 , Kate Brain  3 , John Britton  4   2 , Harriet D Quinn-Scoggins  3 , Sarah Lewis  4   2 , Grace M McCutchan  3 , Samantha L Quaife  5 , Qi Wu  6 , Alex Ashurst  7 , David Baldwin  8 , Philip A J Crosbie  9 , Richard D Neal  10 , Steve Parrott  6 , Suzanne Rogerson  11 , Rebecca Thorley  4   2 , Matthew Ej Callister  12
Affiliations

Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme

Rachael L Murray et al. BMJ Open. .

Abstract

Introduction: Integration of smoking cessation (SC) into lung cancer screening is essential to optimise clinical and cost effectiveness. The most effective way to use this 'teachable moment' is unclear. The Yorkshire Enhanced Stop Smoking study will measure the effectiveness of an SC service integrated within the Yorkshire Lung Screening Trial (YLST) and will test the efficacy of a personalised SC intervention, incorporating incidental findings detected on the low-dose CT scan performed as part of YLST.

Methods and analysis: Unless explicitly declined, all smokers enrolled in YLST will see an SC practitioner at baseline and receive SC support over 4 weeks comprising behavioural support, pharmacotherapy and/or a commercially available e-cigarette. Eligible smokers will be randomised (1:1 in permuted blocks of random size up to size 6) to receive either an enhanced, personalised SC support package, including CT scan images, or continued standard best practice. Anticipated recruitment is 1040 smokers (January 2019-December 2020). The primary objective is to measure 7-day point prevalent carbon monoxide (CO) validated SC after 3 months. Secondary outcomes include CO validated cessation at 4 weeks and 12 months, self-reported continuous cessation at 4 weeks, 3 months and 12 months, attempts to quit smoking and changes in psychological variables, including perceived risk of lung cancer, motivation to quit smoking tobacco, confidence and efficacy beliefs (self and response) at all follow-up points. A process evaluation will explore under which circumstances and on which groups the intervention works best, test intervention fidelity and theory test the mechanisms of intervention impact.

Ethics and dissemination: This study has been approved by the East Midlands-Derby Research Ethics Committee (18/EM/0199) and the Health Research Authority/Health and Care Research Wales. Results will be disseminated through publication in peer-reviewed scientific journals, presentation at conferences and via the YLST website.

Trial registration numbers: ISRCTN63825779, NCT03750110.

Keywords: CT; protocols & guidelines; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: PAJC has received consultation fees and share options from Everest Detection.

Figures

Figure 1
Figure 1
Flow diagram illustrating the path of participants through the study, interventions and evaluations. LDCT, low-dose CT; SCP, smoking cessation practitioner; YLST, Yorkshire Lung Screening Trial; SSS, stop smoking service
Figure 2
Figure 2
Example of a booklet page for (A) participant with no visible emphysema; (B) participant with ‘moderate’ emphysema; (C) participant with ‘severe’ emphysema; (D) participant with no visible coronary artery calcification (CAC); (E) participant with CAC.
See this image and copyright information in PMC

References

    1. Cancer Research UK Cancer incidence for common cancers. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics/i... [Accessed 10 Oct 2019].
    1. Riaz SP, Horton M, Kang J, et al. . Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol 2011;6:2005–10.10.1097/JTO.0b013e31822b02db - DOI - PubMed
    1. Office for National Statistics Smoking (General lifestyle survey overview - a report on the 2011 general lifestyle survey), 2013.
    1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409.10.1056/NEJMoa1102873 - DOI - PMC - PubMed
    1. Humphrey LL, Teutsch S, Johnson M, et al. . Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. preventive services Task force. Ann Intern Med 2004;140:740–53.10.7326/0003-4819-140-9-200405040-00015 - DOI - PubMed

Publication types

Associated data